LLY logo

LLY
Lilly(Eli) & Co

30,087
Mkt Cap
$816.66B
Volume
5.02M
52W High
$935.63
52W Low
$623.78
PE Ratio
42.67
LLY Fundamentals
Price
$840.48
Prev Close
$813.53
Open
$837.50
50D MA
$780.49
Beta
0.61
Avg. Volume
3.48M
EPS (Annual)
$11.71
P/B
44.71
Rev/Employee
$958,355.32
Loading...
Loading...
News
all
press releases
Company News for Oct 31, 2025
Companies in The News Are: WDC,LLY,IP,CAH
Zacks·1d ago
News Placeholder
More News
News Placeholder
Meta investors think Mark Zuckerberg is living dangerously, says Jim Cramer
'Mad Money' host Jim Cramer recaps earnings for Apple, Amazon, Eli Lilly, Meta and more...
CNBC Television-YouTube·2d ago
News Placeholder
Jim Cramer recaps Thursday's slate of earnings and what they signal about the economy
'Mad Money' host Jim Cramer recaps earnings for Apple, Amazon, Eli Lilly, and more...
CNBC Television-YouTube·2d ago
News Placeholder
Mizuho's Holtz talks what is behind Novo's bid for Metsera
Jared Holz, Mizuho, joins 'Fast Money' to recap Novo Nordisk's bid for Metsera and ELi Lilly soaring after earnings beat...
CNBC Television-YouTube·2d ago
News Placeholder
We're raising our Eli Lilly price target what a difference a quarter makes
The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications...
CNBC: Healthcare·2d ago
News Placeholder
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year sales and earnings outlook.
Zacks·2d ago
News Placeholder
Eli Lilly CEO Dave Ricks Reportedly Says Company Eyeing Pain Relief Market With Weight Loss Drug Retatrutide
CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain.
Stocktwits·2d ago
News Placeholder
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Eli Lilly chairman and CEO David Ricks joins CNBC's Squawk on the Street team to discuss its quarterly earnings report that beat estimates, weight loss drug demand, its drug pipeline and more...
CNBC Television-YouTube·2d ago
News Placeholder
Pre-markets Down on Questions: Fed, Jobs & Q3 Earnings
Weekly Jobless Claims are not out again this Thursday morning, for the fifth straight week.
Zacks·2d ago
News Placeholder
Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics
The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·2d ago

Latest LLY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.